文献速递血栓与止血

发热伴血小板减少综合征病毒在血小板内复制并增强血小板活化

Severe fever with thrombocytopenia syndrome virus replicates in platelets and enhances platelet activation.
PubMed 文献 · J Thromb Haemost · 2023-02-13

本研究采用健康志愿者和发热伴血小板减少综合征(SFTS)患者的血小板,结合分子对接、表面等离子共振、流式细胞术及体外功能实验,发现血小板可容纳并产生SFTS病毒颗粒,病毒通过结合血小板糖蛋白VI增强血小板活化,且血小板与巨噬细胞相互作用促进病毒清除但巨噬细胞内病毒复制又加重病毒持续存在,可能参与血小板减少和不良预后。

要点

  • 血小板可容纳并产生SFTS病毒颗粒,首次证实血小板支持病毒复制。
  • SFTS病毒结合血小板糖蛋白VI,增强血小板聚集、ATP释放、铺展、血块回缩、凝血、磷脂酰丝氨酸暴露、血栓形成和黏附。
  • 血小板与巨噬细胞互作促进病毒清除并抑制巨噬细胞因子产生,但巨噬细胞内病毒复制又加重病毒持续存在。

核心结论

  • 血小板在针对SFTS病毒感染的初始内在防御中具有病理生理作用,并与宿主免疫交织,也可能导致血小板减少和不良预后。

研究设计与样本

  • 使用健康志愿者和SFTS患者的血小板,评估其对SFTS病毒感染的功能变化。
  • 通过定量实时PCR、分子对接、表面等离子共振光谱、流式细胞术、蛋白质印迹和体外血小板功能研究,探讨糖蛋白VI对血小板-SFTS病毒相互作用的直接影响。
  • 通过扫描电子显微镜、定量实时PCR和流式细胞术,测定SFTS病毒及血小板-SFTS病毒复合物与巨噬细胞的相互作用。

主要发现

  • 本研究首次证明血小板能够容纳并产生SFTS病毒颗粒。
  • 结构和功能研究发现,SFTS病毒结合血小板糖蛋白VI,增强血小板活化,包括血小板聚集、三磷酸腺苷释放、铺展、血块回缩、凝血、磷脂酰丝氨酸暴露、血栓形成和黏附。
  • 体外机制研究强调,血小板与人THP-1细胞相互作用促进SFTS病毒清除并抑制巨噬细胞中的细胞因子产生。
  • 然而,巨噬细胞中不需要的SFTS病毒复制反过来加重了病毒在循环中的持续存在,这可能促成SFTS病毒感染期间的血小板减少和其他并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe fever with thrombocytopenia syndrome (SFTS) virus (SFTSV) infection causes an emerging hemorrhagic fever in East Asia with a high mortality rate. Thrombocytopenia is a consistent feature of SFTS illness, but the mechanism remains elusive. OBJECTIVES: We aimed to better understand the role of platelets in the pathophysiology of SFTSV infection, including the development of thrombocytopenia. METHODS: Using platelets from healthy volunteers and patients with SFTS, we evaluated the functional changes in platelets against SFTSV infection. We investigated the direct effect of glycoprotein VI on platelet-SFTSV interaction by quantitative real-time PCR, molecular docking, surface plasmon resonance spectrometry, flow cytometry, western blot, and platelet functional studies in vitro. Interactions of SFTSV and platelet-SFTSV complexes with macrophages were also determined by scanning electron microscope, quantitative real-time PCR, and flow cytometry. RESULTS: This study is the first to demonstrate that platelets are capable of harboring and producing SFTSV particles. Structural and functional studies found that SFTSVs bind platelet glycoprotein VI to potentiate platelet activation, including platelet aggregation, adenosine triphosphate release, spreading, clot retraction, coagulation, phosphatidylserine exposure, thrombus formation, and adherence. In vitro mechanistic studies highlighted that the interaction of platelets with human THP-1 cells promoted SFTSV clearance and suppressed cytokine production in macrophages. However, unwanted SFTSV replication in macrophages reciprocally aggravated SFTSV persistence in the circulation, which may contribute to thrombocytopenia and other complications during SFTSV infection. CONCLUSION: These findings together highlighted the pathophysiological role of platelets in initial intrinsic defense against SFTSV infections, as well as intertwined processes with host immunity, which can also lead to thrombocytopenia and poor prognosis.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Fang L, Yu S, Tian X, et al. Severe fever with thrombocytopenia syndrome virus replicates in platelets and enhances platelet activation. J Thromb Haemost. 2023. PMID: 36792011. doi:10.1016/j.jtha.2023.02.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。